Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Previously Untreated B-CLL
NCT00771056Phase 2Terminated
- Sponsor
- Northwell Health
- Start
- Jul 2008
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydroxychloroquine in chronic lymphocytic leukemia (CLL), sponsored by Northwell Health. Primary endpoint: Percentage of Participants With Response at 1 year. Started Jul 2008; status: terminated.
02
Drugs
hydroxychloroquine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00771056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771056.